DNA Methylation
DNA methylation captures intervention effects at a systems level, delivering earlier, higher-resolution signal than traditional biomarkers across pharmacologic, nutritional, and behavioral studies.

120+ Interventional Trials with Pharma, Academic & Life Science Partners
OVER 80+ academic PARTNERSHIPS
Why DNA Methylation Matters for Interventional Trials
On its own, DNA hints at which diseases may develop and which areas of resilience a patient may possess, giving clues to how that person’s healthspan may unfold. In this way, DNA resembles a hard copy road map: good at showing the big picture, but static and missing crucial details.
Supplementing DNA with epigenetic methylation pattern recognition yields a much richer depiction of how a person’s genomic journey is progressing. By analyzing methylation and Epigenetic Biomarker Proxies (EBPs), researchers and clinicians can more clearly discern which genomic possibilities are becoming realities. This enables more targeted interventions and a better understanding of how to lower diseases and promote resiliency for each individual person.
How to Get the Most Out of DNA Methylation in Your Research
Interventional research depends on statistical power and biological coverage. TruDiagnostic has built the world’s largest DNA methylation dataset, enabling partners to analyze intervention effects across diverse populations and contexts. Paired with purpose-built analytical software, this foundation supports faster signal detection, deeper stratification, and more confident conclusions.
DNA methylation captures biological change across multiple physiological systems. Partners can interrogate aging dynamics, treatment response, disease risk, and mechanism-level signals—supporting applications ranging from companion diagnostics and drug development to OMICs and bioinformatics research.
Our datasets are designed for reuse, not single-read outcomes. Researchers can examine intervention effects across time, re-analyze cohorts as new hypotheses emerge, and apply future biomarker frameworks without the need to recollect samples–maximizing the long-term value of each study.
We extend the value of methylation data through proprietary algorithms and epigenetic models that surface meaningful associations, reduce biological noise, and translate high-dimensional data into interpretable, trial-relevant insights.
Our research partners benefit from custom arrays and multi-clock algorithms to make real differences in real clients’ lives.
Do Interventions Change DNA Methylation?
For example, well-designed interventions can remove undesirable methyl groups and free up binding sites in CpG islands, reactivating healthy gene expression; they can also promote positive methylation, helping prevent diseases and maintain healthy cellular functions.
Using appropriate arrays, bisulfite sequencing, biological clock models, and computational algorithms, our partner researchers can gain insights into the impact of various interventions with greater power and precision than ever before.
Supercharge Your Next Interventional Trial With DNA Methylation
When you partner with us, you gain access not only to a database of epigenetic data from the largest DNAm database in the world – spanning more than 80,000 patients – but also the analytic tools and experts to make sense of it all.
TruDiagnostic lets you sift through genomic data with greater speed and precision and test your hypotheses more robustly. Because you are accessing an entire set of biological aging algorithms and not just a single model, your research studies are set up for success from the beginning. More specimens, more data, more experience, and more meaningful conclusions. It all adds up to better research and better overall care.
.png)
.png)


.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)

.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)

.png)
.png)
.png)
.png)
.png)
.png)
.png)
